18 June 2013
Keywords: york, pharma, acquires, molecular, skincare, uk, alternative
Article | 07 February 2005
York Pharma, a UK Alternative Investment Market-listed acquirer, developer and marketer of dermatology products, has purchased Molecular SkinCare, which develops ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.